One of the limitations to this study is the sample size, which could explain why we did not find a significant decrease of YKL-40 after RYGB or any significant associations of YKL-40 with MCP-1, measures of obesity, lipids, or glucose metabolism. The gene discussed is CCL2; the disease is obesity disorder.